Fourier Intelligence, a Chinese smart rehab startup known for its robotic exoskeletons, recently received 400 million yuan ($63.27 million) in series D financing, which was led by Softbank Vision Fund 2, followed by Vision Plus Capital as well as Prosperity7 Ventures, a venture capital fund owned by Saudi Aramco.
Gu Jie, Founder and CEO of Fourier Intelligence, said that the funds raised in this round will be used to further develop the company’s intelligent robot technology and accelerate the implementation and deployment of rehabilitation robot products on a global scale.
Founded in 2015, the intelligent robot company focuses on improving the core technology of high-performance robots and building an intelligent robot technology platform. The technology is often applied in the physical rehabilitation industry.
There is a huge demand for rehabilitation tools and instruments in China’s medical market. According to Qianzhan Industry Research Institute, it is estimated that the scale of the rehabilitation medical market will exceed 200 billion yuan ($31.63 billion) in 2025.
Starting with physical rehabilitation robots, Fourier Intelligence has been able to provide comprehensive solutions for rehabilitation institutions that require smart rehabilitation products, physical therapy equipment and the digitalization of rehabilitation medical services, thus forming a closed-loop service.
Up to now, the company’s self-developed rehabilitation robots have been exported to dozens of countries and regions and settled in more than 1,000 institutions at home and abroad. The company is headquartered in Zhangjiang, Shanghai, while it has set up a regional headquarters in Singapore. It conducts R&D and production layout in Beijing, Shanghai, Guangzhou, Zurich and Chicago in an effort to establish a global network for R&D, production and services.
The startup has independently developed core technologies and components such as force feedback technology platform, multi-joint robot motion control cards and multi-dimensional force sensors, and got rid of the import dependence of software and hardware.
The company plans to release a pan-bionic robot platform and apply core technologies to more non-rehabilitation fields in the future.